106 related articles for article (PubMed ID: 18171985)
1. Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastoma.
Voth H; Oberthuer A; Simon T; Kahlert Y; Berthold F; Fischer M
Mol Cancer Res; 2007 Dec; 5(12):1276-84. PubMed ID: 18171985
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
4. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
Oberthuer A; Hero B; Spitz R; Berthold F; Fischer M
Clin Cancer Res; 2004 Jul; 10(13):4307-13. PubMed ID: 15240516
[TBL] [Abstract][Full Text] [Related]
5. The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32.
Spieker N; van Sluis P; Beitsma M; Boon K; van Schaik BD; van Kampen AH; Caron H; Versteeg R
Genomics; 2001 Jan; 71(2):214-21. PubMed ID: 11161815
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.
Oberthuer A; Skowron M; Spitz R; Kahlert Y; Westermann F; Mehler K; Berthold F; Fischer M
Gene; 2005 Dec; 363():41-50. PubMed ID: 16216448
[TBL] [Abstract][Full Text] [Related]
7. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
Grosfeld JL; Rescorla FJ; West KW; Goldman J
Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
[TBL] [Abstract][Full Text] [Related]
10. Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastoma.
Voth H; Oberthuer A; Simon T; Kahlert Y; Berthold F; Fischer M
BMC Mol Biol; 2009 Apr; 10():28. PubMed ID: 19348682
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses.
Beierle EA; Massoll NA; Hartwich J; Kurenova EV; Golubovskaya VM; Cance WG; McGrady P; London WB
Clin Cancer Res; 2008 Jun; 14(11):3299-305. PubMed ID: 18519756
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
Machida T; Fujita T; Ooo ML; Ohira M; Isogai E; Mihara M; Hirato J; Tomotsune D; Hirata T; Fujimori M; Adachi W; Nakagawara A
Oncogene; 2006 Mar; 25(13):1931-42. PubMed ID: 16288218
[TBL] [Abstract][Full Text] [Related]
13. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
[TBL] [Abstract][Full Text] [Related]
14. ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma.
Kobayashi K; Era T; Takebe A; Jakt LM; Nishikawa S
Cancer Res; 2006 Sep; 66(17):8331-6. PubMed ID: 16951138
[TBL] [Abstract][Full Text] [Related]
15. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F
J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of cell cycle genes distinguishes aggressive neuroblastoma.
Krasnoselsky AL; Whiteford CC; Wei JS; Bilke S; Westermann F; Chen QR; Khan J
Oncogene; 2005 Feb; 24(9):1533-41. PubMed ID: 15592497
[TBL] [Abstract][Full Text] [Related]
17. Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation.
Geerts D; Wallick CJ; Koomoa DL; Koster J; Versteeg R; Go RC; Bachmann AS
Clin Cancer Res; 2007 Nov; 13(21):6312-9. PubMed ID: 17975142
[TBL] [Abstract][Full Text] [Related]
18. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T
Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934
[TBL] [Abstract][Full Text] [Related]
19. Modified PCR methods for 3' end amplification from serial analysis of gene expression (SAGE) tags.
Xu WJ; Wang ZX; Qiao ZD
FEBS J; 2009 May; 276(10):2657-68. PubMed ID: 19459930
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression analysis of cDNA ends of chicken neuropathy target esterase.
Chang PA; Sun Q; Ni XM; Qv FQ; Wu YJ; Song FZ
Chem Biol Interact; 2008 Mar; 172(1):54-62. PubMed ID: 18191825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]